first day of tirzepatide side effects Effects. What You Shouldn't Ignore What to Expect Before and

Weight Loss Medication Update June 23, 2025 FDA permission for compounding of GLP-1 medications used for weight loss ends April 22

The impact of retatrutide on cardiovascular disease Retatrutide doesnt have an equivalent cardiovascular outcomes trial yet

What results should I expect after starting a GLP-1 activator

Integrative analysis of mutational and transcriptional profiles reveals driver mutations of metastatic breast cancers

Reddys Laboratories said on Thursday it has temporarily halted commercial production of its generic semaglutide after identifying an issue with the active pharmaceutical ingredient (API)

Cathepsin L activity controls adipogenesis and glucose tolerance